BioSpace News Archive

IMPOYZ Cream is the only FDA-approved high-potency topical corticosteroid with 0.025% clobetasol propionate.

new breakthrough methodology that assesses extra virgin olive oil’s authenticity is gaining momentum in the field of nutrition and food science.

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2018 financial results on Tuesday, May 8, 2018, before the opening of the U.S. financial markets.

David T. Feinberg, M.D., MBA, Geisinger president and CEO, will make a major announcement during his presentation at the HLTH Conference, on May 6th at the Aria in Las Vegas.

Research Solutions, Inc. will hold a conference call on Tuesday, May 15, 2018 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal third quarter ended March 31, 2018.

Regulus Therapeutics Inc. announced that it has initiated a Phase I multiple ascending dose (MAD) study in healthy volunteers for RGLS4326 for the treatment of autosomal dominant polycystic kidney disease, or ADPKD

Birner Dental Management Services, Inc. (OTCQX: BDMS), business services provider of PERFECT TEETH™ dental practices, will conduct a conference call to review first quarter 2018 results.

- Arena’s non-core, proprietary, preclinical compound provides strategic fit with Outpost Medicine’s expertise in developing products for genitourinary disorders

Sensus Healthcare, Inc. announced the appointment of Rita Gable as its Vice President of Sales - Oncology, effective immediately.

QIDP provides five additional years of market exclusivity, and Fast Track expedites the regulatory path Enrollment completed in Phase 2b DOVE study in VVC; on-track for top-line data by July 2018 Initiation of Phase 3 registration program in VVC planned for the fourth quarter of 2018, with potential NDA filing in 2020